Juvena Therapeutics, Inc.
Other Technology · Redwood City, California
Juvena Therapeutics, Inc. is a other technology company based in Redwood City, California, incorporated in 2017. It has reported $34.8 million raised across 2 Form D filings with the SEC, most recently in 2025.
Unlocking the therapeutic potential of secreted proteins Restoring tissue health and rejuvenating lives Protein signaling dysregulation leads to degenerative diseases Juvena maps the therapeutic potential of natural secreted proteins and engineers them into biologics that restore tissue homeostasis Restoring tissue health by repairing protein signaling and intercellular communication Secreted proteins are released by cells to […]
| Date | Round | Amount | Raised to date | Lead investor | Source |
|---|---|---|---|---|---|
| 2025-07-25 | — | $30.5M | $34.8M | SEC Form D | |
| 2018-02-26 | — | $4.3M | $4.3M | SEC Form D |
SEC rows are Form D filings, where the amount is what was actually sold and amendments update a round rather than adding one. Press rows are split between company-issued releases or wires and editorial or third-party coverage. The total is therefore a floor: a round nobody reported is a round we cannot see. A buyout or control change appears in the timeline but is never added to the total: that money goes to shareholders, not into the company.
Form D is the notice a company files with the SEC when it sells securities without registering them. It reports the amount sold, not a valuation. Figures here are what the filing says. Where a filing is silent, the field is left blank rather than estimated. “Total raised” adds press-reported rounds that never appear in a filing, so it is a floor rather than an audited sum: press amounts are the figures the company announced, and a round nobody reported is a round we cannot see.